ACR–ACNM–ARS–SNMMI PRACTICE PARAMETER FOR LUTETIUM-177 (Lu-177) DOTATATE THERAPY

PREAMBLE

I. INTRODUCTION

II. INDICATIONS

III. QUALIFICATIONS AND RESPONSIBILITIES OF PERSONNEL

IV. SPECIFICATIONS OF THE EXAMINATION AND TREATMENT

V. DOCUMENTATION

VI. STATEMENT OF THERAPEUTIC USE OF UNSEALED RADIOPHARMACEUTICAL SOURCES

VII. EQUIPMENT SPECIFICATIONS

VIII. RADIATION SAFETY

IX. QUALITY CONTROL AND IMPROVEMENT, SAFETY, INFECTION CONTROL, AND PATIENT EDUCATION

ACKNOWLEDGEMENTS

REFERENCES

Appendix A